Executive Interviews

ASX-listed Broken Hill Prospecting Limited is a mining and exploration company seeking to develop the significant Pyrite Hill, Big Hill and Railway cobalt deposits located 25 kilometres south-west of the world famous mining centre of Broken Hill in western New South Wales.

Property Assistant is a unique online real estate marketing and management system, providing real estate agents with low cost/high result property marketing techniques not currently available in the industry.

TopBetta is the world’s first social betting platform for sports and racing tournaments that enables sports fans to compete against each other, rather than the bookie. The service tackles the sour taste left in the mouths of punters by the ‘bookie always wins’ nature of traditional gaming.  

Scott Power is a Senior Analyst with RBS Morgans.

Mr Stephen Baxter is an independent director of Vocus Communications and has an extensive background in starting Internet based companies in Australia and working overseas on large-scale data networks.

BioPower Systems is focused on developing advanced technologies which convert the energy in waves and tides to grid-ready electricity. Developed by a group of professional engineers with a deep understanding of the challenges posed by harnessing ocean energy, the designs address all the problems that have been experienced by other technologies.

Phylogica Limited (ASX: PYC) is a biotechnology company based in Perth, Australia and Oxford UK, with a world-class drug discovery platform harnessing the rich biodiversity of nature to discover novel peptide therapeutics.

Just as other industries have moved successfully onto the Internet (Airfares, Employment, Accommodation, Real Estate, etc), Jumbo has successfully taken Lotteries onto the Internet. Jumbo has developed and grown www.ozlotteries.com into a very popular place for Australians to buy their regular lottery tickets with annual sales exceeding $70 million pa.

Mesynthes is a soft-tissue reconstruction company using its proprietary Endoform technology to develop regenerative tissue substitutes for reconstructive surgery and wound care. These markets represent an opportunity in excess of US$1B.